AIM
ONCY

Acuity Investment Management’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Acuity Investment Management’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-69,300
Closed -$108K – 154
2013
Q4 		$108K Sell
69,300
-11,087,706
-99% -$25M 0.04% 122
2013
Q3 		$27.1M Sell
11,157,006
-1,813,733
-14% -$5.02M 3.7% 6
2013
Q2 		$37.2M Buy
+12,970,739
New +$35.9M 4.8% 4

Other funds holding ONCY

1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
AII
AGF Investments Inc Toronto, Ontario, Canada $10.6B AUM 4.37% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $62.7B AUM 37.65% 1-Year Est. Return

Acuity Investment Management's ONCY Position: Q1 2014 in Review

Acuity Investment Management sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q1 2014, closing a stake of 69,300 shares — an estimated $108K sold.

Acuity Investment Management first reported a position in ONCY in Q2 2013 and held it in 3 quarters. The position peaked at $37.2M in Q2 2013. 34 funds tracked by Wall St. Rank hold ONCY as of Q1 2014.

  • Acuity Investment Management reported no remaining ONCOLYTICS BIOTECH INC position as of Q1 2014 after selling out during the quarter.
  • Acuity Investment Management sold 69,300 ONCOLYTICS BIOTECH INC shares in Q1 2014, an estimated $108K.
  • Acuity Investment Management first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 3 quarters.
  • Acuity Investment Management's ONCOLYTICS BIOTECH INC position peaked at $37.2M in Q2 2013.
  • 34 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q1 2014.

Based on Acuity Investment Management's 13F filing for Q1 2014, filed 6 May 2014.